The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
No fee travel credit cards come with key benefits that can enhance your travel experience. Learn what they are to make informed choices.
26,188 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...
As AI tax prep tools surge this season, experts warn that convenience can come with risky gaps. taxpayers weigh speed...
As market conditions shift in 2026, VFIAX remains a top pick for buy-and-hold strategies. The fund combines a low 0.0...
GM-owned Cruise has reached more settlements related to a pedestrian drag incident involving its autonomous taxi, wit...
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
Ripple's XRP is the sole crypto on CNBC's 2026 Disruptor 50 list, ranked 16th and labeled 'new money.' The milestone ...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
Two tech giants reported divergent Q1 results as they sprint into AI. Meta dominates ads but burns cash on Reality La...
Crypto dollars are moving from the sidelines to the heart of American politics, with record 2024 spending and a growi...
A seemingly small line in Nvidia's latest earnings release hints at a larger shift toward edge computing. For investo...
A growing share of young workers juggle caregiving with early careers, and traditional retirement planning often miss...